Thyroid Nodule (Benign) Clinical Trials
2 recruiting trials for Thyroid Nodule (Benign). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Thyroid Nodule (Benign) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Chinese PLA General Hospital (1), Royal Berkshire NHS Foundation Trust (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is ultrasound-guided thermal ablation (procedure, 1 trial), followed by Thyroid artery embolization.
Track Thyroid Nodule (Benign) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules
To evaluate long-term outcomes of ultrasound-guided thermal ablation for benign thyroid nodules
Thyroid Artery Goitre Embolization Trial A Pilot Study Investigating Thyroid Artery Embolisation as a Treatment for...
Large non-cancerous thyroid nodules (lumps in the thyroid gland) can cause pressure or discomfort in the neck or cosmetic issues. The standard treatment options include...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Thyroid Nodule (Benign), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Thyroid Nodule (Benign), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Thyroid Nodule (Benign), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.